Author: GlobalCONTACT

New sizes for BostonSightSCLERAL

New sizes for BostonSightSCLERAL

BostonSight announced the expansion of its BostonSight SCLERAL lens diameter options with the introduction of three new sizes: 14.5mm, 15.0mm, and 15.5mm. The new sizes are available together in a single FitKit trial set and include lenses for both right and left eyes. With this launch, BostonSight SCLERAL now offers a complete diameter range from…

Optometry students equipped with the necessary skills

Optometry students equipped with the necessary skills

CooperVision recently hosted its 2026 Summit at the company’s global headquarters in Victor, N.Y., as part of its Student Contact Lens and Myopia Leadership Society, according to an announcement from the company. This year-long professional development program is designed to equip optometry students with the necessary skills for clinical practice and leadership, underscoring CooperVision’s ongoing commitment to…

Successful integration

Successful integration

RevolutionEHR, a leading cloud-based electronic health record (EHR) and practice management platform for optometry, has announced a new integration with Dr. Contact Lens, a prescription management platform focused on helping practices retain more contact lens revenue while improving patient compliance. By securely connecting patient demographics and contact lens prescription data within RevolutionEHR, Dr. Contact Lens will…

New consumer and professional research

New consumer and professional research

Contact Lens Institute™ (CLI) and the United Opticians Association (UOA) today announced new consumer and professional research that illustrates opticians’ vital roles in optimizing contact lens experiences, including high levels of patient trust. Opticians themselves report having multiple contact lens-related responsibilities, yet also desire additional involvement and education. The findings are now available as a…

Contamac received FDA premarket approval of Optimum Infinite material

Contamac received FDA premarket approval of Optimum Infinite material

Contamac announces FDA Premarket approval (PMA) of Optimum Infinite (tisilfocon A) material for use in orthokeratology overnight wear. Contamac, a global leader in specialty contact lens and intraocular lens materials today announced U.S. Food and Drug Administration (FDA) Premarket approval for the Optimum Infinite (tisilfocon A) Orthokeratology Lenses II. Outside the USA, this approval in…

BostonSight wants to redefine ocular surface treatment

BostonSight wants to redefine ocular surface treatment

In February, BostonSight announced a transformative 5-year strategic roadmap aimed at redefining ocular surface treatment through groundbreaking advancements in clinical research, education, and specialty lens technology. The organization has designated key leadership roles to lead initiatives that accelerate innovation and collaboration, with the goal of positively impacting patient lives around the world. Dr. Karen Carrasquillo,…

Alcon reports 7% CL sales uptick in Q4

Alcon reports 7% CL sales uptick in Q4

Alcon reported $683 million in contact lens sales for Q4 2025, a 7 percent year-on-year increase driven by new product launches and price increases, particularly in North America. Price resistance was stronger elsewhere: “If you look at the European market, you have got a lot of big chains who basically are telling us they are…

Specialty Contact Lens Travel Grants by Art Optical

Specialty Contact Lens Travel Grants by Art Optical

Art Optical Contact Lens, Inc., a provider of custom contact lenses, in partnership with Contamac, a manufacturer of contact and intraocular lens materials, recently named the winners of their Specialty Contact Lens Travel Grants. According to the announcement, these individuals have demonstrated the use of Art Optical lens designs to solve patient needs in unique…

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon Co., Ltd, a global contact lens manufacturer, announced that it has concluded its Rose K manufacturing partnership with Blanchard Contact Lenses, a division of CooperVision, effective December 31, 2025. Blanchard had been an important and valued Rose K partner since 2003, the company said, contributing more than two decades of expertise to the fitting,…

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics, Inc., a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, has announced certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. Approved by the FDA in August 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related presbyopia….